Consolidated Statements of Changes in Shareholders' Deficit (Parenthetical) - USD ($) $ in Millions			3 Months Ended		9 Months Ended
	Jul. 01, 2021	Dec. 30, 2019	Sep. 30, 2021		Sep. 30, 2021	Sep. 30, 2020	Jan. 31, 2020	Dec. 31, 2019
Common stock (in dollars per share)		$ 0.25	$ 0.01		$ 0.01	$ 0.01	$ 0.01	$ 0.25
Common stock, shares outstanding (in shares)			101.34		101.34	101.34	101.34
Net proceeds from sale of business / assets					$ 13.9	$ 11.3
Sale of Avon Luxembourg	$ 148.0		$ 148.4	[1]
Converted Series C Convertible Preferred Stock (in shares)		87,000,000
Stock, shares authorized (in shares)		1,525,000,000						1,525,000,000
Common stock, authorized (in shares)		1,500,000,000					1,000	1,500,000,000
Preferred stock, authorized (in shares)		25,000,000						25,000,000
Preferred stock, par value (in dollars per share)		$ 1.00					$ 0.01	$ 1.00
Stock converted or cancelled (in shares)							550,890,788
Avon Luxembourg Holdings
Net proceeds from sale of business / assets	$ 150.0
Series C Preferred Stock
Shares converted (in shares)		435,000

[1] On July 1, 2021, the Company sold Avon Luxembourg Holdings S.à r.l. and its subsidiaries ("Avon Luxembourg"), including our Mexican business, to a subsidiary of Natura &Co Holding S.A. for $150. The sale was accounted for as a transaction under common control in accordance with ASC805 - Business Combinations, with the resulting gain of $148, representing the difference between the proceeds, the net assets of Avon Luxembourg on the date of sale, and the cumulative foreign currency translation adjustment, taken directly to Retained Earnings.